Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors
Oncotarget2018Vol. 9(82), pp. 35293–35299
Citations Over TimeTop 18% of 2018 papers
Abstract
SII was a robust indicator of tumor differentiation and one-year survival in elderly patients with newly diagnosed solid tumors. Patients in the high SII group showed poor tumor differentiation and poor prognosis compared to patients with a low SII score.
Related Papers
- → Dynamics of life expectancy and life span equality(2020)255 cited
- → What happened to life expectancy in Spain in the 1980s?(1997)18 cited
- → THE ASSESSMENT OF PRIORITIES FOR INCREASING LIFE EXPECTANCY IN RUSSIA(2014)
- Healthy Life Expectancy and Health Gains in Cardiovascular Diseases Management in Korea(2012)
- → A 21-YEAR DYNAMICS IN CONTRIBUTION OF MORTALITY FROM CURABLE DISEASES TO THE DECREASE IN LIFE EXPECTANCY IN THE KRASNOYARSK TERRITORY(2022)